FindTrial
Sign In

OXCARBAZEPINE VS PHENYTOIN IN THE TREATMENT OF SEIZURES IN PATIENTS WITH BRAIN TUMORS UNDERGOING NEUROSURGICAL PROCEDURES

OXCARBAZEPINE VS PHENYTOIN IN THE TREATMENT OF SEIZURES IN PATIENTS WITH BRAIN TUMORS UNDERGOING NEUROSURGICAL PROCEDURES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-001562-13-IT
Enrollment
Unknown
Registered
2007-05-11
Start date
2006-02-03
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SEIIZURES IN PATIENTS WITH BRAIN TUMORS MedDRA version: 9.1 Level: LLT Classification code 10053551 Term: Intractable epilepsy

Interventions

Trade Name: TOLEP*50CPR DIV 600MG Pharmaceutical Form: Tablet INN or Proposed INN: Oxcarbazepine CAS Number: 28721-07-5 Concentration unit: mg milligram(s) Concentration type: equal Concentration numb

Sponsors

AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026